Mesenchymal Autologous Stem Cells

· Haukeland University Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mesenchymal Autologous Stem Cells, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis [Phase 1, Phase 2]